CD69 and tuberculosis: Mid-treatment ATB patients showed a notable increase in effector memory AIM+ (p=0.006) cells alongside a significant decline in central memory subsets (p=0.03) compared to ATB at diagnosis, indicating that anti-TB therapy alters the composition of antigen-specific memory T cell responses.